TrueForm® Fascial Release
The first supplement built to address the densified fascia driving neuropathy pain — with trial results the neuropathy space has never seen before.
Where TrueForm® Came From
In early 2025, a small group of clinical researchers was doing a straightforward comparison. On one side, the studies and trials that had come out of connective tissue labs over the previous three years. On the other, the standard of care that neuropathy patients were actually being offered.
The gap was staggering.
The research had been quietly converging on a finding that standard neuropathy care hadn't caught up to: a specific tissue in the body, called fascia, appeared to be playing a much larger role in chronic neuropathy than anyone had realized. And nothing on the shelf had been built to address it.
Here is what that research had established.
Fascia is the connective tissue that fills the empty space inside the body. It wraps every muscle, surrounds every organ, and holds nearly every peripheral nerve in place.
In a healthy body, fascia is soft, hydrated, and fluid. It behaves like a wet, slippery cushion around everything it wraps. Peripheral nerves run through it freely, firing without any pressure or friction from the tissue around them. Nothing is felt from the fascia because nothing is supposed to be felt from it. It is invisible by design.
Fascia only stays that way because the body continuously supplies it with the specific nutrients that keep it hydrated.
What the research had documented is that in the bodies of people with chronic neuropathy, the fascia surrounding the peripheral nerves had dried out and densified. The soft, hydrated cushion had hardened into something closer to shrink-wrap. And that hardened tissue was doing two things to the nerves running through it.
It was physically compressing them. And it was rubbing against them, damaging them over time, the way any healthy tissue would be damaged by being pressed and abraded by something rigid twenty-four hours a day.
Not sometimes. Not during flares. Every hour of every day, for years.
The compression and the friction are what produce the classic neuropathy symptom picture. The burning at night is nerves being squeezed and abraded by tissue that used to cushion them. The numbness in the hands and feet is compression choking the signal. The tingling and the pins and needles are misfires from nerves under constant physical pressure and damage. Every symptom the standard shelf tries to quiet or medicate around traces back to the same place. A layer of connective tissue that was supposed to protect the nerves is now the thing hurting them.
Millions of people with neuropathy had been told for decades that the damage was permanent. That the best they could do was manage the pain.
The research was pointing to a different story. But nobody had translated it into anything a patient could actually take.
The team decided that if nobody else was going to build for it, they would.
They spent the better part of a year on the formulation. What came out of it is what we know today as TrueForm® Fascial Release.
How It Was Built
The formulation wasn't fast.
The team started from a specific question: what would it actually take to rehydrate fascia that had been densifying for years?
Nothing on the existing neuropathy shelf could answer it. Alpha-lipoic acid, B12, gabapentin, Lyrica, Cymbalta, capsaicin, TENS units — every intervention in the category is aimed at the nerve itself. None of them are aimed at the tissue compressing the nerve. Which is why the pattern repeats for so many people: two weeks of maybe something, then nothing, then the drawer where the bottle ends up.
The science of fascia is very new. Almost no serious research existed on this system until the last five years. Nutrient work on fascia specifically was even newer. Nobody had ever built a supplement around it because until very recently, there was nothing to build one around.
What's In It
As the fascia rehydrates and the densification lifts, the pressure on the peripheral nerves releases. The burning quiets. The numbness lifts. The tingling changes. Not because the nerves have been medicated — because the tissue compressing them has finally been addressed.
What Happened When They Released It
In early 2026, the first production run of TrueForm® went to a cohort of 1,272 adults with a formal neuropathy diagnosis. Every participant had already failed at least two interventions from the standard shelf. The team tracked their symptoms across a 90-day window.
By day 90, the numbers that came back changed everything.
The team tested this formulation for 90 days. That's the same window offered to every customer.
Any customer who takes TrueForm® for the full 90 days and doesn't feel a real difference by the end of it gets a full refund. No shipping the pouches back. No forms to fill out justifying the decision. No conditions.
If the formulation reduces the burning, the numbness, and the tingling in the majority of people who have already tried everything on the standard shelf, standing behind it should not be complicated.
Why Starting Sooner Matters
Densified fascia doesn't rehydrate on its own.
Left alone, it goes in one direction. It hardens further. It presses on the nerves harder. It rubs against them longer. And every day that passes is another day of damage the nerves absorb.
That matters because peripheral nerve damage doesn't heal the same way fascia can. Modern medicine still has no reliable way to reverse damage to the nerves themselves. The amount of nerve damage present today is, in most cases, as good as it's going to get.
Every week the fascia is left to keep compressing them is a week of damage that can't be undone.
The reason to start sooner isn't urgency for its own sake. It is that the fascia is the one variable that can still be changed. The nerves cannot be repaired after the fact. The tissue compressing them can be.
One in the morning, one at night. With or without food. Compatible with everything currently used in the neuropathy space: gabapentin, Lyrica, Cymbalta, ALA, B12, methylcobalamin, over-the-counter supplements, and every prescription in the standard pool. No known interactions. No need to come off anything to begin.
From People Who Had Stopped Expecting Anything to Move
Practitioner allocation first
The last thing worth knowing is that TrueForm® is not always in stock.
It's manufactured in small clinical batches in an FDA-registered, GMP-certified facility in the US. A portion of every batch is reserved for the 500+ physicians and clinicians distributing it within their practices. Whatever remains is released to the public, first-come, first-served.
When a batch sells out, the next one takes six to eight weeks to produce, and customers already on the protocol are placed ahead of new customers for restocks.
If TrueForm® is in stock right now, this is an invitation to join the thousands of people who are already on it.
